Your browser doesn't support javascript.
loading
Is radioembolization or sorafenib the best option for patients with hepatocellular carcinoma and portal vein invasion?
Liao, Ying-Yang; Zhong, Jian-Hong; Peng, Ning-Fu; Li, Le-Qun; Tong, Tie-Jun.
Affiliation
  • Liao YY; Department of Oncology Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.
  • Zhong JH; Department of Oncology Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.
  • Peng NF; Department of Oncology Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.
  • Li LQ; Department of Oncology Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.
  • Tong TJ; Department of Mathematics, Hong Kong Baptist University, Hong Kong, Hong Kong.
Liver Int ; 36(11): 1715, 2016 11.
Article in En | MEDLINE | ID: mdl-27454762
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Portal Vein / Carcinoma, Hepatocellular Limits: Humans Language: En Journal: Liver Int Journal subject: GASTROENTEROLOGIA Year: 2016 Document type: Article Affiliation country: China Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Portal Vein / Carcinoma, Hepatocellular Limits: Humans Language: En Journal: Liver Int Journal subject: GASTROENTEROLOGIA Year: 2016 Document type: Article Affiliation country: China Country of publication: United States